Abbott (NYSE:ABT) and Cardiovascular Systems, Inc. (CSI), today announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million.
Ontrak Stock Is Up More Than 100% Today: What’s Going On?
Ontrak Inc (NASDAQ: OTRK) shares are trading significantly higher Wednesday after the company announced new data showing a reduction in depression and anxiety symptoms for